BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Deals

  Zalicus Inc. Announces Closing Of CHTS Service Business Sale To Horizon Discovery Group

  June 2, 2014

   · 

  1 min read
• Drug Development

  CEL-SCI Receives Approval To Expand Its Immunotherapy Phase 3 Head And Neck Cancer Trial Into The United Kingdom

  June 2, 2014

   · 

  1 min read
• Drug Development

  NewLink Genetics Presents Algenpantucel-L Clinical Data In Poster Discussion Session At American Society of Clinical Oncology 2014 Annual Meeting

  June 2, 2014

   · 

  9 min read
• BioMidwest

  NewLink Genetics Demonstrates Continuing IDO Pathway Inhibitor Progress At American Society of Clinical Oncology 2014 Annual Meeting

  June 2, 2014

   · 

  6 min read
• Drug Development

  NOXXON Pharma AG’s Emapticap Pegol Study Selected For Late Breaking Clinical Trials Symposium During ERA-EDTA Conference

  June 2, 2014

   · 

  1 min read
• Drug Development

  Medivation, Inc. Release: The New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naive Metastatic Prostate Cancer Progressing Despite Androgen Deprivation Therapy

  June 2, 2014

   · 

  7 min read
• Biotech Bay

  Threshold Pharmaceuticals, Inc. Announces Presentation And Webcast At The Jefferies and Co. Global Healthcare Conference

  June 2, 2014

   · 

  2 min read
• Drug Development

  Tokai Pharmaceuticals Presents New Clinical Data For Galeterone Among Patients With Advanced Prostate Cancer At American Society of Clinical Oncology 2014

  June 2, 2014

   · 

  1 min read
• Drug Development

  Prima Biomed To Host Conference Call To Discuss Abstract Presented At American Society of Clinical Oncology On New Interim Overall Survival And Final Progression Free Survival Data For The Company’s CAN-003 Trial

  June 2, 2014

   · 

  3 min read
• Drug Development

  Cellceutix Completes Patient Enrollment In Clinical Trial Of Prurisol

  June 2, 2014

   · 

  5 min read